Strategic Management and Sustainability

Strategic Management
and Sustainability

Table of Contents
INTRODUCTION ..........................................................................................................................3
MAIN BODY ..................................................................................................................................3
Key business strategies of AstraZeneca......................................................................................3
Resource capabilities of AstraZeneca.........................................................................................6
Environmental sustainability approaches of AstraZeneca..........................................................8
CONCLUSION..............................................................................................................................11
REFERENCES .............................................................................................................................12
Book And Journals ..................................................................................................................12

INTRODUCTION
Strategic management is termed to be as the analysis of market and resource s that a
business organisation is required for managing services and products to met the goals of the
organisation by opting the corrective method and ways for the improvement. Strategical
management support organisation to harness the capabilities by working on the weak area that is
sustainability which is next big thing in doing business in 21st century. AstraZeneca, a
pharmaceutical company in the modern business operation sunder the COVID-19 shadow is
experiencing high pressure and company thriving to add on sustainability in its strategic
management approach and practices(Kravchenko, Pigosso and McAloone, 2019). Thereafter,
following report cover the strategical management practices of AstraZeneca who is looking
forward to rethink its strategies due to changing business environment and business operations
because of the novel pandemic COVID-19. Following report covers the key business strategies
of AstraZeneca by using porter's generic and Ansoff model to highlighted why there need to
pursued and adopt changes. Also, report throw light on the resources and capabilities of the
company along with the finding how AstraZeneca can implement environmental sustainability in
order to become more competitive in pharmaceutical industry.
MAIN BODY
Key business strategies of AstraZeneca
Pharmaceutical industry is a high margin industry in the world and only flourishing
industry in COVID-19 crisis. AstraZeneca is a British-Swedish pharmaceutical and
biotechnology company which is producing and manufacturing high class medicine and also
COVID- 19 Vaccine. The company has business strategy and business driven by innovative
science to focus on the life-changing medicines in order to achieve scientific leadership goals by
being committed to execute a centred innovation-driven global biopharmaceuticals strategy
(Daddi and et. al., 2019). The key business strategies of the company can be better understand by
using following model and concepts-
Porter's generic strategical framework
Porter's generic strategies model is used by the AstraZencea in evaluating the business
strategies to achieve competitive advantages. In order to evaluate and identify the key business

strategies of AstraZencea porter's generic is ideal choice which help in identification of potential
place in which company can gain competitive advantages.
Cost leadership strategies
AstraZeneca opt cost leadership strategies with aim to transforming medicine flow to the
patients by establishing themselves as the low cost producer in pharmaceutical industry in UK.
Cost leadership strategies relates to the gaining competitive advantages by way of lowering the
cost of the product offering, this is the main strategy which AstraZenca is using in various
consumer markets since last 5 years. The primary aim of selecting this strategy is to take niche in
the market leadership position though an efficient value chain management. Also, this business
strategy allows the firm to expends the market share through targeting the middle class which is
the largest group in the overall population of UK (Naciti, 2019). When company focusing on the
being cost leadership in the market they focus on the affordability and easy accessibility to its
product not within the UK but across the world and this further lead towards the high brand
awareness and high economic and profit margin for the company (AstraZeneca outlines strategy
to return to growth and achieve scientific leadership 2021). Other than this when AstraZeneca is
choosing cost leadership strategies they are maximising their supply chain effectiveness which
increase the brand popularity and encourage consumption.
Differentiation strategy
Differentiation is a kind of another armoury business strategy of AstraZeneca which
company is using along with the cost leadership strategies since few last years in order to achieve
competitive advantages and growth in the market. Through differentiation strategies company
expands the customer base by grandness over the unique product feature. The main objective
behind using this strategy is to differentiate by thriving the innovation and indicate the
consumers growing health concern (De and et. al., 2020). For instance AstraZeneca has drawn-
out its product line after analysing the consumer changing interest because of growing industry
rival so in order to differentiate itself from its industry rival company is using differentiation
strategy of business strategies to build storing and loyal customer base (Our Company –
AstraZeneca, 2021). People can observe company's differentiation thorough its extensive
experiencing in the pharmaceutical industry and the oldest and strong brand in the UK to product
COVID-19 vaccine along with the Pizer company and strong presence across the globe are the